Examining Trans-infection of HIV in Isolated Dendritic Cells

检查分离树突状细胞中 HIV 的转染情况

基本信息

  • 批准号:
    7599039
  • 负责人:
  • 金额:
    $ 4.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-25 至 2011-02-24
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Human Immunodeficiency Virus (HIV) is a retrovirus that destroys the immune system, causing the devastating disease known as the acquired immune deficiency syndrome (AIDS). In order to accomplish these effects, HIV subverts host defenses, altering normal functions to its own advantage. Dendritic cells (DCs) are antigen presenting cells that capture and process incoming pathogens, in order to present antigenic peptides to T lymphocytes and thereby elicit an immune response. Since DCs are among the first cells to encounter incoming HIV, the virus:cell interaction has been the focus of considerable research. Recent studies have found DCs are capable of capturing HIV and retaining the virus in an infectious state, then enhancing viral delivery to target cells in co-culture thereby increasing HIV infectivity. However, the mechanism involved in each of these processes remains unknown. This project will focus on identification of the endocytic pathway used by HIV to avoid degradation and characterization of the intracellular storage compartment within DCs. To achieve these goals, endocytic pathways will be suppressed through use of various chemicals and dominant negative constructs. The ability of DCs to pass infectious HIV to target cells in trans following each treatment will be determined through use of a luciferase reporter viral construct. High resolution fluorescent microscopy will be employed to examine the intracellular storage compartment in great detail. HIV will be visualized through use of a fluorescently tagged viral construct, and various markers of endocytic compartments will be used to characterize the storage compartment. The chemicals used to block endocytic pathways will also be examined for their ability to alter intracellular trafficking of HIV. Additionally, the effect of DC maturation on endocytosis and intracellular storage will be examined through the methods detailed above. Relevance: With over 40 million people currently living with HIV/AIDS worldwide, there is a constant need for development of better therapeutics and more efficient prevention strategies. As DCs are the first cells to encounter incoming HIV, targeting DCs directly may prove to be a successful approach to vaccine development. This proposal will answer important questions about the mechanism of HIV capture and storage by DCs, thereby contributing to the overall understanding of the HIV:DC interaction.
描述(由申请人提供):人类免疫缺陷病毒(HIV)是一种破坏免疫系统的逆转录病毒,导致称为获得性免疫缺陷综合征(AIDS)的毁灭性疾病。为了达到这些效果,HIV破坏了宿主的防御,改变了正常的功能。树突状细胞(DC)是抗原呈递细胞,其捕获和处理进入的病原体,以便将抗原肽呈递给T淋巴细胞,从而引发免疫应答。由于树突状细胞是第一个遇到传入的艾滋病毒的细胞,病毒:细胞相互作用一直是相当多的研究的重点。最近的研究发现,DC能够捕获HIV并将病毒保持在感染状态,然后在共培养中增强病毒向靶细胞的递送,从而增加HIV感染性。然而,这些过程中的每一个所涉及的机制仍然未知。本项目将重点鉴定HIV使用的内吞途径,以避免DC内细胞内储存区室的降解和表征。为了实现这些目标,内吞途径将通过使用各种化学品和显性负结构来抑制。将通过使用荧光素酶报告病毒构建体来确定DC在每次处理后将感染性HIV反式传递至靶细胞的能力。高分辨率荧光显微镜将被用来详细检查细胞内储存区室。将通过使用荧光标记的病毒构建体来可视化HIV,并且将使用内吞隔室的各种标志物来表征储存隔室。还将检查用于阻断内吞途径的化学物质改变HIV细胞内运输的能力。此外,将通过上述方法检查DC成熟对内吞作用和细胞内储存的影响。相关性:目前全世界有4 000多万人感染艾滋病毒/艾滋病,因此不断需要开发更好的治疗方法和更有效的预防战略。由于树突状细胞是第一个遇到传入的艾滋病毒的细胞,直接靶向树突状细胞可能被证明是一种成功的疫苗开发方法。该提案将回答有关DC捕获和储存HIV的机制的重要问题,从而有助于对HIV:DC相互作用的全面理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHEILA M BARRY其他文献

SHEILA M BARRY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了